Stereotactic Radiotherapy for Oligo-Progressive Metastatic Cancer (The STOP Trial)
Stereotactic Radiotherapy for Oligo-Progressive Metastatic Cancer (The STOP Trial)
Active, not recruiting · NCT02756793 · Registry updated 2025-12-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Stereotactic Radiotherapy for Oligo-Progressive Metastatic Cancer (The STOP Trial) | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, metastatic malignant neoplasm, neoplasm | Active, not recruiting | Not applicable | 2025-12-31 | NCT02756793 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 148 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Alberta Health Services-Cross Cancer Institute | Edmonton | Canada | 1 |
| BC Cancer - Prince George | Prince George | Canada | 3 |
| BC Cancer - Victoria Centre | Victoria | Canada | 1 |
| BC Cancer Agency Branch | Vancouver | Canada | 1 |
| BC Cancer Fraser Valley Centre | Surrey | Canada | 1 |
| London Regional Cancer Program | London | Canada | 40 |
| Princess Margaret Cancer Centre | Toronto | Canada | 3 |